86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details


臨床試験数 : 1,205 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03270332
(ClinicalTrials.gov)
October 5, 201730/8/2017Effect of Inhaled Albuterol in Pulmonary HypertensionEffect of Inhaled Albuterol on Pulmonary Hemodynamics in Patients With Group 1 Pulmonary Arterial Hypertension on Oral Pulmonary Vasodilator Therapy: A Proof of Concept StudyPulmonary HypertensionDrug: Albuterol;Drug: PlaceboUniversity of MiamiNULLCompleted18 YearsN/AAll10Phase 2United States
2NCT02782052
(ClinicalTrials.gov)
July 201617/5/2016Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial HypertensionBronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial HypertensionPulmonary Arterial HypertensionDrug: Nebulized ipratropium bromide;Drug: Nebulized combination ipratropium bromide with salbutamol;Drug: Nebulized PlaceboAssistance Publique - Hôpitaux de ParisNULLWithdrawn18 YearsN/AAll0Phase 3NULL
3EUCTR2014-002590-10-FR
(EUCTR)
11/02/201602/03/2016Effect of bronchodilators on effort induced dyspnoea in lung hypertension patientsEffect of bronchodilators on effort induced dyspnoea in patients suffering lung hypertension - BD-HTAP Idiopathic or heritable patients with pulmonary arterial hypertension (PAH).
MedDRA version: 18.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Trade Name: Bromure d'Ipratropium
Product Name: Bromure d'Ipratropium
INN or Proposed INN: Bromure d'Ipratropium
Trade Name: Salbutamol
Product Name: Salbutamol
INN or Proposed INN: Salbutamol
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNot RecruitingFemale: yes
Male: yes
18Phase 3France
4NCT02108743
(ClinicalTrials.gov)
June 20147/4/2014Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial HypertensionAlbuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial Hypertension.Drug: Albuterol.;Drug: Normal saline placeboAmerican Medical Association FoundationNULLWithdrawn18 Years75 YearsBoth0Phase 2United States